Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Effectiveness of High-Dose MTX Therapy for Adult Ph-Negative ALL By Randomized Trial: JALSG ALL202-O

Toru Sakura, Fumihiko Hayakawa, MD PhD, Isamu Sugiura, MD PhD, Kiyotoshi Imai, MD PhD, Noriko Usui, MD, Shin Fujisawa, MD, Tohru Murayama, Toshiaki Yujiri, MD PhD, Hitoshi Kiyoi, MD PhD, Kazunori Ohnishi, MD PhD, Yasushi Miyazaki, MD, Shigeki Ohtake, MD PhD, Yukio Kobayashi, MD PhD, Keitaro Matsuo, MDPhD, Tomoki Naoe, MD PhD

Blood (2015) 126 (23): 79.

https://doi.org/10.1182/blood.V126.23.79.79

Published: 2015

Journal Articles

Impact of Ph+ Stem Cell Burden on Clinical Findings and Molecular Responses to First-Line Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia: The Results from the Interim Analysis of N-Road, Multi-Center a Phase II Study

Mayuko Tsuda, MD, Kaichi Nishiwaki, MD PhD, Kei-ji Sugimoto, MD PhD, Hisayuki Yokoyama, MD PhD, Tadahiko Igarashi, MD PhD, Seiichi Shimizu, MD PhD, Toshiaki Yujiri, MD PhD, Hisashi Wakita, MD PhD, Arinobu Tojo, MD PhD

Blood (2014) 124 (21): 3159.

https://doi.org/10.1182/blood.V124.21.3159.3159

Published: 2014

Journal Articles

The Efficacy and Long-Term Outcomes of ASCT in POEMS Syndrome: A Multicenter Retrospective Study in Japan

Chika Kawajiri, MD, Emiko Sakaida, MD PhD, Chikako Ohwada, MD PhD, Toshihiro Miyamoto, MD PhD, Taichi Azuma, MDPhD, Jun Taguchi, MD PhD, Takehiko Mori, MD PhD, Yuichi Hasegawa, MD PhD, Tadakazu Kondo, MD PhD, Toshiaki Yujiri, MD PhD, Makoto Yoshimitsu, MDPhD, Mitsuru Tsudo, Toshihiko Iwasaki, MD PhD, Akio Shigematsu, MD PhD, Ritsuro Suzuki, MD PhD, Yoshiko Atsuta, MDPhD, Makoto Hirokawa, MD PhD, Hisashi Sakamaki, MDPhD, Chiaki Nakaseko, MD PhD

Blood (2014) 124 (21): 3970.

https://doi.org/10.1182/blood.V124.21.3970.3970

Published: 2014

Journal Articles

The Anti-Apoptotic Role of the Unfolded Protein Response in Bcr-Abl Positive Leukemia Cells.

Atsuko Tanimura, MSc, Toshiaki Yujiri, MD, PhD, Yoshinori Tanaka, MD, Yukio Tanizawa, MD, PhD

Blood (2007) 110 (11): 4527.

https://doi.org/10.1182/blood.V110.11.4527.4527

Published: 2007

Journal Articles

Activation of the Unfolded Protein Response in Acute Leukemia and Myeloma.

Toshiaki Yujiri, MD, PhD, Atsuko Tanimura, Kozo Tagami, MD, Yukinori Nakamura, MD, Yukio Tanizawa, MD, PhD

Blood (2005) 106 (11): 4348.

https://doi.org/10.1182/blood.V106.11.4348.4348

Published: 2005

Journal Articles

BCR-ABL Activates STAT3 Via MEK Kinase 1 in Embryonic Stem Cells.

Yukinori Nakamura, MD, Toshiaki Yujiri, MD, PhD, Ryouhei Nawata, MD, PhD, Kozo Tagami, MD, Yukio Tanizawa, MD, PhD

Blood (2004) 104 (11): 4320.

https://doi.org/10.1182/blood.V104.11.4320.4320

Published: 2004

NARROW

Effectiveness of High-Dose MTX Therapy for Adult Ph-Negative ALL By Randomized Trial: JALSG ALL202-O

Impact of Ph+ Stem Cell Burden on Clinical Findings and Molecular Responses to First-Line Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia: The Results from the Interim Analysis of N-Road, Multi-Center a Phase II Study

The Efficacy and Long-Term Outcomes of ASCT in POEMS Syndrome: A Multicenter Retrospective Study in Japan

The Anti-Apoptotic Role of the Unfolded Protein Response in Bcr-Abl Positive Leukemia Cells.

Activation of the Unfolded Protein Response in Acute Leukemia and Myeloma.

BCR-ABL Activates STAT3 Via MEK Kinase 1 in Embryonic Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Effectiveness of High-Dose MTX Therapy for Adult Ph-Negative ALL By Randomized Trial: JALSG ALL202-O

Impact of Ph+ Stem Cell Burden on Clinical Findings and Molecular Responses to First-Line Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia: The Results from the Interim Analysis of N-Road, Multi-Center a Phase II Study

The Efficacy and Long-Term Outcomes of ASCT in POEMS Syndrome: A Multicenter Retrospective Study in Japan

The Anti-Apoptotic Role of the Unfolded Protein Response in Bcr-Abl Positive Leukemia Cells.

Activation of the Unfolded Protein Response in Acute Leukemia and Myeloma.

BCR-ABL Activates STAT3 Via MEK Kinase 1 in Embryonic Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only